PT1463541E - Biomateriais à base de éster benzílico de ácido hialurónico destinados à terapêutica anti-angiogénica no tratamento de tumores - Google Patents

Biomateriais à base de éster benzílico de ácido hialurónico destinados à terapêutica anti-angiogénica no tratamento de tumores Download PDF

Info

Publication number
PT1463541E
PT1463541E PT03700315T PT03700315T PT1463541E PT 1463541 E PT1463541 E PT 1463541E PT 03700315 T PT03700315 T PT 03700315T PT 03700315 T PT03700315 T PT 03700315T PT 1463541 E PT1463541 E PT 1463541E
Authority
PT
Portugal
Prior art keywords
use according
hyaluronic acid
biomaterial
benzyl ester
hyaff
Prior art date
Application number
PT03700315T
Other languages
English (en)
Portuguese (pt)
Inventor
Alessandra Pavesio
Norbert E Fusenig
Hans-Juergen Stark
Michael Willhauck
Original Assignee
Fidia Farmaceutici
Deutsches Krebsforsch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Farmaceutici, Deutsches Krebsforsch filed Critical Fidia Farmaceutici
Publication of PT1463541E publication Critical patent/PT1463541E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT03700315T 2002-01-11 2003-01-07 Biomateriais à base de éster benzílico de ácido hialurónico destinados à terapêutica anti-angiogénica no tratamento de tumores PT1463541E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002PD000003A ITPD20020003A1 (it) 2002-01-11 2002-01-11 Biomateriali a base di acido ialuronico come terapia anti-angiogenicanella cura dei tumori.

Publications (1)

Publication Number Publication Date
PT1463541E true PT1463541E (pt) 2010-01-07

Family

ID=11452500

Family Applications (1)

Application Number Title Priority Date Filing Date
PT03700315T PT1463541E (pt) 2002-01-11 2003-01-07 Biomateriais à base de éster benzílico de ácido hialurónico destinados à terapêutica anti-angiogénica no tratamento de tumores

Country Status (12)

Country Link
US (1) US7838510B2 (enExample)
EP (1) EP1463541B1 (enExample)
JP (1) JP4603263B2 (enExample)
AT (1) ATE448809T1 (enExample)
AU (1) AU2003201618B2 (enExample)
CA (1) CA2472880C (enExample)
DE (1) DE60330113D1 (enExample)
DK (1) DK1463541T3 (enExample)
ES (1) ES2334497T3 (enExample)
IT (1) ITPD20020003A1 (enExample)
PT (1) PT1463541E (enExample)
WO (1) WO2003057203A2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITPD20040312A1 (it) * 2004-12-15 2005-03-15 Fidia Advanced Biopolymers Srl Protesi e o supporto per la sostituzione, riparazione, rigenerazione del menisco

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6117A (ja) * 1984-06-11 1986-01-06 Seikagaku Kogyo Co Ltd ムコ多糖系癌転移抑制剤
US4851521A (en) 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
IT1219587B (it) 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
US5143724A (en) * 1990-07-09 1992-09-01 Biomatrix, Inc. Biocompatible viscoelastic gel slurries, their preparation and use
IT1254704B (it) * 1991-12-18 1995-10-09 Mini Ricerca Scient Tecnolog Tessuto non tessuto essenzialmente costituito da derivati dell'acido ialuronico
CA2094203A1 (en) * 1993-04-16 1994-10-17 Derek A. Willoughby Inhibition of angiogenesis
ITPD940054A1 (it) * 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
RU2177332C2 (ru) * 1995-08-29 2001-12-27 Фидиа Адвансд Биополимерз, С.Р.Л. Биоматериал для предотвращения послеоперационных спаек, включающий производные гиалуроновой кислоты (варианты) и способ предотвращения послеоперационных спаек ткани
ATE229038T1 (de) * 1997-04-04 2002-12-15 Fidia Advanced Biopolymers Srl N-sulfatierte hyaluronsäureverbindungen, ihre derivate und verfahren zu ihrer herstellung
IT1293484B1 (it) * 1997-06-11 1999-03-01 Fidia Advanced Biopolymers Srl Materiale biologico comprendente una efficiente coltura di cellule e una matrice tridimensionale biocompatibile e biodegradabile
US6872819B1 (en) * 1998-05-27 2005-03-29 Fidia Advanced Biopolymers S.R.L. Biomaterials containing hyaluronic acid derivatives in the form of three-dimensional structures free from cellular components or products thereof for the in vivo regeneration of tissue cells
ITPD980169A1 (it) * 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione.
CA2365767A1 (en) * 1999-03-15 2000-09-21 Trustees Of Boston University Angiogenesis inhibition
WO2000057896A1 (en) 1999-03-26 2000-10-05 The University Of Texas System Modulators of polysaccharides and uses thereof
IT1317359B1 (it) * 2000-08-31 2003-06-16 Fidia Advanced Biopolymers Srl Polisaccaridi percarbossilati, quali l'acido ialuronico, processo perla loro preparazione e loro impiego in campo farmaceutico e
IT1317358B1 (it) * 2000-08-31 2003-06-16 Fidia Advanced Biopolymers Srl Derivati cross-linkati dell'acido ialuronico.
AU2002239697A1 (en) * 2000-10-24 2002-06-03 Clear Solutions Biotech, Inc. Sodium hyaluronate microspheres

Also Published As

Publication number Publication date
US20050037049A1 (en) 2005-02-17
AU2003201618B2 (en) 2008-11-06
AU2003201618A1 (en) 2003-07-24
CA2472880A1 (en) 2003-07-17
EP1463541B1 (en) 2009-11-18
EP1463541A2 (en) 2004-10-06
DK1463541T3 (da) 2010-03-08
JP4603263B2 (ja) 2010-12-22
DE60330113D1 (de) 2009-12-31
CA2472880C (en) 2011-08-16
WO2003057203A3 (en) 2003-12-31
ATE448809T1 (de) 2009-12-15
US7838510B2 (en) 2010-11-23
ES2334497T3 (es) 2010-03-11
JP2005524619A (ja) 2005-08-18
ITPD20020003A1 (it) 2003-07-11
WO2003057203A2 (en) 2003-07-17

Similar Documents

Publication Publication Date Title
Thierry et al. Bioactive coatings of endovascular stents based on polyelectrolyte multilayers
US11744926B2 (en) Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications
Belotti et al. The microtubule-affecting drug paclitaxel has antiangiogenic activity.
US11890344B2 (en) One-step processing of hydrogels for mechanically robust and chemically desired features
Li et al. Reinforced collagen with oxidized microcrystalline cellulose shows improved hemostatic effects
Yuan et al. Fibrous dressing containing bioactive glass with combined chemotherapy and wound healing promotion for post-surgical treatment of melanoma
JP2007515949A5 (enExample)
Sontyana et al. Biopolymeric in situ hydrogels for tissue engineering and bioimaging applications
JP2009513696A (ja) 内部局所放射線治療用生物分解可能な複合体
US11986489B2 (en) Method of treating a disease using a glycolytic dependent compound
Bouta et al. Biomaterial guides for lymphatic endothelial cell alignment and migration
ES2334497T3 (es) Biomateriales basados en ester bencilico de acido hialuronico para terapia anti-angiogenica en el tratamiento de tumores.
Mi et al. Bioprinted integrated gradient biomechanical signal-tailored osteosarcoma model: advancing insights into tumor development and drug screening
CN101361686A (zh) 一种血管药物支架
Huang et al. Stiffness-optimized drug-loaded matrix for selective capture and elimination of cancer cells
Sasmal et al. Dual drug-loaded self-wearable electrospun nanofibers for synergistic pharmacological intervention through tertiary hemostasis in prehospital trauma care
Uhljar et al. In vitro drug release permeability, and structural test of ciprofloxacin-loaded nanofibers. Pharmaceutics. 2021; 13: 556
US20220054527A1 (en) Method of treating a disease using a glycolytic dependent compound
Hobbs Transvascular transport of sterically stabilized liposomes and particles in transplanted tumors
CZ2017634A3 (cs) Supramolekulární komplex oxycelulózové matrice s platinovým metalokomplexem s postupným uvolňováním platinového metalokomplexu a jeho použití
CZ307237B6 (cs) Supramolekulární komplex oxycelulózové matrice s taxolovým derivátem s postupným uvolňováním taxolového derivátu a jeho použití
Franke The 21th Congress on Clinical Hemorheology and Microcirculation of the German Society, Ulm, Germany, 20–25 October 2002
HK1255223B (en) Improved cancer treatment with doxorubicin
CZ307155B6 (cs) Supramolekulární komplex oxycelulózové matrice s antracyklinovým cytostatikem s postupným uvolňováním antracyklinového cytostatika a jeho použití
De Marco Production of Mesoglycan/PCL Based Composites through Supercritical Impregnation